Cost-Benefit Analysis of Active Vaccination Campaigns Against Hepatitis A Among Daycare Centre Personnel in Israel

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.19, Iss.3, 2001-03, pp. : 281-291

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-Benefit Analysis of Vaccination against Tick-Borne Encephalitis among French Troops

By Desjeux Guillaume

PharmacoEconomics, Vol. 23, Iss. 9, 2005-01 ,pp. : 913-926

Adis International

Access to resources Recommend Favorite

Cost-Benefit Analysis of Haemophilus influenzae Type b Vaccination in Children in Spain

By Jiménez F.J.

PharmacoEconomics, Vol. 15, Iss. 1, 1999-01 ,pp. : 75-83

Adis International

Access to resources Recommend Favorite

Cost-Benefit Analysis of Risperidone and Clozapine in the Treatment of Schizophrenia in Israel

By Ginsberg G.

PharmacoEconomics, Vol. 13, Iss. 2, 1998-02 ,pp. : 231-241

Adis International

Access to resources Recommend Favorite

Cost-Benefit Analysis of Amtolmetin-Guacil

By Belisari A. Mantovani L.G.

Clinical Drug Investigation, Vol. 21, Iss. 1, 2001-01 ,pp. : 47-58

Adis International

Access to resources Recommend Favorite

An introduction to cost-effectiveness and cost–benefit analysis of pharmacogenomics

By Phillips Kathryn A Veenstra David Bebber Stephanie Van Sakowski Julie

Pharmacogenomics, Vol. 4, Iss. 3, 2003-05 ,pp. : 231-239

Future Medicine

Access to resources Recommend Favorite